Pharma Journalist -

Bristol Myers Squibb announced that the European Commission (EC) has granted Conditional Marketing Authorization for Abecma (idecabtagene vicleucel; ide-cel), a first-in-class B-cell…
Read More...

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced the launch of its MaxSignal Mycotoxin Automation Bundle. Using the new assays and automation…
Read More...

In draft guidance published today (19 August 2021), NICE has recommended midostaurin (Rydapt, Novartis) as a treatment for advanced systemic mastocytosis in adults. Mastocytosis is a…
Read More...

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced plans to expand its commercial manufacturing capacity at its Rensselaer, New…
Read More...

Sorrento Therapeutics, Inc. a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19. The publication details preclinical…
Read More...

The 6th Annual Microbiome Connect: USA is taking place in Boston on 17-18 November 2021. For the first time ever, this year, the two-day conference will incorporate a specific two-day…
Read More...

Alligator Bioscience announced that the company has entered into a research collaboration and license agreement with Orion Corporation, a global pharmaceutical company based in Finland,…
Read More...

NRx Pharmaceuticals (NRx) a clinical stage, biopharmaceutical company provided a safety update on ZYESAMI (aviptadil) which is being tested in the ACTIV-3 Critical Care Phase 3 study…
Read More...

Roche announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company's commitment to personalised healthcare through tests that…
Read More...

Jardiance (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of cardiovascular death plus hospitalization for heart failure in adults…
Read More...